Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 8, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Technology
Trinity Life Sciences Unveils Digital Affinity Platform to Enhance HCP Engagement
Life Sciences Times
-
August 12, 2025
0
Technology
VideaHealth Lands No. 28 Spot on 2025 Inc. 5000 Fastest-Growing Companies List
Life Sciences Times
-
August 12, 2025
0
Medtech
First FDA-Approved Treatment for MacTel Administered Following Commercial Launch
Life Sciences Times
-
August 11, 2025
0
Pharma
Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide
Life Sciences Times
-
August 11, 2025
0
Medtech
FDA Clears Thermo Fisher Test to Match Lung Cancer Patients With Newly Approved HER2-Targeted Drug
Life Sciences Times
-
August 11, 2025
0
Venture Capital
SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team
Life Sciences Times
-
August 11, 2025
0
Pharma
KalVista Drug for Hereditary Angioedema Keeps Orphan Status in EU
Life Sciences Times
-
August 11, 2025
0
Pharma
First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment
Life Sciences Times
-
August 11, 2025
0
Medtech
Tandem Diabetes Care Issues Voluntary Correction for Select t:slim X2 Insulin Pumps Due to Malfunction Risk
Life Sciences Times
-
August 8, 2025
0
Technology
BostonGene Wins “AI-based Drug Discovery Solution of the Year” at 2025 AI Breakthrough Awards
Life Sciences Times
-
August 8, 2025
0
1
...
133
134
135
...
835
Page 134 of 835
Most Popular
Museum of Science Raises Record $1.8 Million at Stars of STEM Gala
May 7, 2026
enGene Reports Updated Interim Results From Bladder Cancer Trial
May 7, 2026
Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award
May 7, 2026
Scholar Rock Reports First-Quarter Results as FDA Review of Apitegromab Advances
May 7, 2026
Load more
Recent Comments
Recent Comments